


Searching News Database: Augmentin
HSMN NewsFeed - 4 Jan 2021
Biohaven Begins Pivotal Phase 3 Trial Of Troriluzole In Obsessive-Compulsive Disorder
Biohaven Begins Pivotal Phase 3 Trial Of Troriluzole In Obsessive-Compulsive Disorder
HSMN NewsFeed - 10 Feb 2020
Biohaven's Troriluzole Study For Generalized Anxiety Disorder (GAD) Misses Primary Endpoint
Biohaven's Troriluzole Study For Generalized Anxiety Disorder (GAD) Misses Primary Endpoint
HSMN NewsFeed - 28 Jan 2020
Beckman Coulter's Access PCT Procalcitonin Assay Receives U.S. FDA 510(k) Clearance
Beckman Coulter's Access PCT Procalcitonin Assay Receives U.S. FDA 510(k) Clearance
HSMN NewsFeed - 5 Dec 2018
Subtle Medical Receives FDA 510(k) Clearance and CE Mark Approval for SubtlePET(TM)
Subtle Medical Receives FDA 510(k) Clearance and CE Mark Approval for SubtlePET(TM)
HSMN NewsFeed - 15 Feb 2018
Arterys Receives First FDA Clearance for Broad Oncology Imaging Suite with Deep Learning
Arterys Receives First FDA Clearance for Broad Oncology Imaging Suite with Deep Learning
HSMN NewsFeed - 29 Jun 2016
Corvus Pharmaceuticals Names Jason V. Coloma to Newly Created Post of Chief Business Officer
Corvus Pharmaceuticals Names Jason V. Coloma to Newly Created Post of Chief Business Officer
HSMN NewsFeed - 7 Oct 2014
CardiacAssist Announces the First Human Use of Its PROTEK DUO(TM) Veno-Venous ECLS Kit
CardiacAssist Announces the First Human Use of Its PROTEK DUO(TM) Veno-Venous ECLS Kit
HSMN NewsFeed - 9 Jun 2014
FDA Grants Edison Pharmaceuticals' EPI-743 Orphan Status for Leigh Syndrome
FDA Grants Edison Pharmaceuticals' EPI-743 Orphan Status for Leigh Syndrome
HSMN NewsFeed - 4 Feb 2013
Stem Cell Therapeutics Announces Agreement With Trillium Therapeutics Inc. for Merger
Stem Cell Therapeutics Announces Agreement With Trillium Therapeutics Inc. for Merger
HSMN NewsFeed - 14 Nov 2011
Torax Medical Receives CE Mark for the FENIX Continence Restoration System
Torax Medical Receives CE Mark for the FENIX Continence Restoration System
HSMN NewsFeed - 22 Dec 2008
EPIX Pharmaceuticals Announces FDA Approval of Vasovist(R) (gadofosveset trisodium)
EPIX Pharmaceuticals Announces FDA Approval of Vasovist(R) (gadofosveset trisodium)
HSMN NewsFeed - 2 Dec 2008
Targeted Genetics Realigns Product Development Priorities and Implements Cost Reduction Measures
Targeted Genetics Realigns Product Development Priorities and Implements Cost Reduction Measures
HSMN NewsFeed - 5 May 2008
Timothy F. Floeder Joins Synovis Life Technologies as Vice President of Corporate Development
Timothy F. Floeder Joins Synovis Life Technologies as Vice President of Corporate Development
HSMN NewsFeed - 16 Apr 2008
Merck Announces Planned Investment of $50 Million in Research Center in the US
Merck Announces Planned Investment of $50 Million in Research Center in the US
HSMN NewsFeed - 28 Mar 2008
Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR
Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR
HSMN NewsFeed - 17 Oct 2007
Phenomix Hires John Crawford as Chief Financial Officer and Appoints Arlene Morris to Board of Directors
Phenomix Hires John Crawford as Chief Financial Officer and Appoints Arlene Morris to Board of Directors
HSMN NewsFeed - 1 May 2007
Robert G. Pietrusko Joins ViroPharma as Vice President of Global Regulatory Affairs and Quality
Robert G. Pietrusko Joins ViroPharma as Vice President of Global Regulatory Affairs and Quality
HSMN NewsFeed - 31 Jan 2007
Ranbaxy Gains FDA Approval to Market Amoxicillin and Clavulanate Potassium for Oral Suspension USP
Ranbaxy Gains FDA Approval to Market Amoxicillin and Clavulanate Potassium for Oral Suspension USP
HSMN NewsFeed - 20 Nov 2006
Orqis(R) Medical Reaches MOMENTUM Pivotal Trial Mid-Point with 100th Patient Enrollment
Orqis(R) Medical Reaches MOMENTUM Pivotal Trial Mid-Point with 100th Patient Enrollment
HSMN NewsFeed - 16 Nov 2006
Shire Announces Results of its Bioequivalence Study of SPD465, an Investigational Drug for Adults with ADHD
Shire Announces Results of its Bioequivalence Study of SPD465, an Investigational Drug for Adults with ADHD
HSMN NewsFeed - 9 Nov 2006
Targacept Announces Positive Results of Phase II Clinical Trial in Major Depression
Targacept Announces Positive Results of Phase II Clinical Trial in Major Depression
HSMN NewsFeed - 22 Sep 2006
Blackstone Medical, Inc. Advances Spine Treatment with New Product Launches at NASS '06
Blackstone Medical, Inc. Advances Spine Treatment with New Product Launches at NASS '06
Additional items found! 63
Members Archive contains
63 additional stories matching:
Augmentin
(Password required)
Augmentin
(Password required)
